China NMPA Drug Inspection - Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory - Ginkgo biloba leaf dispersible tablets
China NMPA drug inspection for Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory published June 22, 2015. Drug: Ginkgo biloba leaf dispersible tablets. The State Food and Drug Administration (SFDA) of China, through Announcement No. 24 of 2015 published on June 22, 2015,
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory published June 22, 2015. Drug: Ginkgo biloba leaf dispersible tablets. The State Food and Drug Administration (SFDA) of China, through Announcement No. 24 of 2015 published on June 22, 2015,
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox